DE60026561D1 - Suppressorzellen zur prävention und behandlung von immunantworten bei transplantationen - Google Patents
Suppressorzellen zur prävention und behandlung von immunantworten bei transplantationenInfo
- Publication number
- DE60026561D1 DE60026561D1 DE60026561T DE60026561T DE60026561D1 DE 60026561 D1 DE60026561 D1 DE 60026561D1 DE 60026561 T DE60026561 T DE 60026561T DE 60026561 T DE60026561 T DE 60026561T DE 60026561 D1 DE60026561 D1 DE 60026561D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- suppressor
- transplantations
- prevention
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002265 prevention Effects 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 2
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46434—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0637—Immunosuppressive T lymphocytes, e.g. regulatory T cells or Treg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1352—Mesenchymal stem cells
- C12N2502/1358—Bone marrow mesenchymal stem cells (BM-MSC)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US415627 | 1999-10-12 | ||
US09/415,627 US6685936B2 (en) | 1999-10-12 | 1999-10-12 | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
PCT/US2000/028011 WO2001026470A1 (en) | 1999-10-12 | 2000-10-10 | Suppressor cells for prevention and treatment of immune responses in transplantation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60026561D1 true DE60026561D1 (de) | 2006-05-04 |
DE60026561T2 DE60026561T2 (de) | 2007-03-15 |
Family
ID=23646488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60026561T Expired - Lifetime DE60026561T2 (de) | 1999-10-12 | 2000-10-10 | Suppressorzellen zur prävention und behandlung von immunantworten bei transplantationen |
Country Status (12)
Country | Link |
---|---|
US (2) | US6685936B2 (de) |
EP (1) | EP1220611B1 (de) |
JP (1) | JP2003511398A (de) |
AT (1) | ATE319312T1 (de) |
AU (1) | AU775647B2 (de) |
CA (1) | CA2382737A1 (de) |
CY (1) | CY1106437T1 (de) |
DE (1) | DE60026561T2 (de) |
DK (1) | DK1220611T3 (de) |
ES (1) | ES2261250T3 (de) |
PT (1) | PT1220611E (de) |
WO (1) | WO2001026470A1 (de) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
US8147824B2 (en) | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
WO2001077299A2 (en) * | 2000-04-11 | 2001-10-18 | University Of Southern California | A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
IL156303A0 (en) | 2000-12-06 | 2004-01-04 | Robert J Hariri | Method of collecting placental stem cells |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
EP1362095B1 (de) * | 2001-02-14 | 2015-05-27 | Anthrogenesis Corporation | Post-partum säugetier-plazenta, deren verwendung und daraus gewonnene stammzellen |
KR101132545B1 (ko) * | 2001-02-14 | 2012-04-02 | 안트로제네시스 코포레이션 | 산후 포유류의 태반, 이의 용도 및 태반 줄기세포 |
EP1487463A2 (de) * | 2002-03-02 | 2004-12-22 | Board Of Regents The University Of Texas System | Lokale produktion und/oder abgabe von anti-krebsmitteln durch vorläufer von stromazellen |
WO2004047770A2 (en) * | 2002-11-26 | 2004-06-10 | Anthrogenesis Corporation | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
KR20050105467A (ko) * | 2003-02-13 | 2005-11-04 | 안트로제네시스 코포레이션 | 질병, 장애 또는 증상을 보유하는 개체의 치료에 있어서제대혈의 용도 |
WO2004090112A2 (en) * | 2003-04-01 | 2004-10-21 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
GB0321337D0 (en) * | 2003-09-11 | 2003-10-15 | Massone Mobile Advertising Sys | Method and system for distributing advertisements |
WO2005055929A2 (en) * | 2003-12-02 | 2005-06-23 | Celgene Corporation | Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
EP2824174B1 (de) | 2004-03-22 | 2018-11-28 | Mesoblast International Sàrl | Mesenchymale stammzellen und verwendungen dafür |
EP1799236B1 (de) * | 2004-09-10 | 2012-05-23 | Cognate Therapeutics, Inc. | Leberstromazellen zur prävention und behandlung von immunantworten bei der transplantation |
US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
CA2512667A1 (en) * | 2005-01-07 | 2006-07-07 | Takahiro Ochiya | Human hepatocyte-like cells and uses thereof |
EP1880002A4 (de) * | 2005-05-10 | 2009-03-11 | Us Health | Therapie von nierenkrankheiten und mehrfachem organversagen mit mesenchymalen stammzellen und durch mesenchymale stammzellen konditionierte medien |
AU2006202209B2 (en) | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
AU2006255183B2 (en) * | 2005-06-08 | 2012-02-02 | Centocor, Inc. | A cellular therapy for ocular degeneration |
EP2530145A1 (de) | 2005-10-13 | 2012-12-05 | Anthrogenesis Corporation | Immunmodulation unter Verwendung von Plazenta-Stammzellen |
US11000546B2 (en) | 2005-11-09 | 2021-05-11 | Athersys, Inc. | Immunomodulatory properties of MAPCs and uses thereof |
US10117900B2 (en) | 2005-11-09 | 2018-11-06 | Athersys, Inc. | MAPC treatment of brain injuries and diseases |
US20070122448A1 (en) * | 2005-11-28 | 2007-05-31 | Alireza Rezania | Compositions and methods to create a vascularized environment for cellular transplantation |
EP1976978A2 (de) | 2005-12-29 | 2008-10-08 | Anthrogenesis Corporation | Cokultur von plazentastammzellen und stammzellen anderen ursprungs |
ES2549111T3 (es) | 2005-12-29 | 2015-10-23 | Anthrogenesis Corporation | Poblaciones de células madre placentarias |
NZ744465A (en) | 2006-01-23 | 2023-04-28 | Abt Holding Co | Mapc therapeutics without adjunctive immunosuppressive treatment |
US8741643B2 (en) * | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
US20080044848A1 (en) * | 2006-06-09 | 2008-02-21 | Heidaran Mohammad A | Placental niche and use thereof to culture stem cells |
US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
NZ606814A (en) | 2006-10-23 | 2014-10-31 | Anthrogenesis Corp | Methods and compositions for treatment of bone defects with placental cell populations |
NZ597779A (en) * | 2007-02-12 | 2013-07-26 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
US20100172830A1 (en) * | 2007-03-29 | 2010-07-08 | Cellx Inc. | Extraembryonic Tissue cells and method of use thereof |
EP2155860B1 (de) | 2007-05-03 | 2014-08-27 | The Brigham and Women's Hospital, Inc. | Multipotente stammzellen und ihre verwendung |
TWM322542U (en) * | 2007-05-23 | 2007-11-21 | Universal Scient Ind Co Ltd | Testing machine |
US9080145B2 (en) * | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
EP2185693B1 (de) | 2007-07-31 | 2019-07-03 | Lifescan, Inc. | Differenzierung menschlicher embryonaler stammzellen |
CN101978045A (zh) * | 2007-09-26 | 2011-02-16 | 细胞基因细胞疗法公司 | 来自人胎盘灌洗液的血管生成细胞 |
EP3524253A1 (de) | 2007-09-28 | 2019-08-14 | Celularity, Inc. | Tumorsuppression mit menschlichem plazentaperfusat und menschlichen natürlichen killerzellen eines zwischenproduktes aus der plazenta |
DK2205721T3 (en) | 2007-10-17 | 2016-10-24 | Txcell | TR1 cells mesenchymal stem cells and uses thereof |
KR20210056449A (ko) * | 2007-11-07 | 2021-05-18 | 안트로제네시스 코포레이션 | 조산 합병증의 치료에 있어서의 제대혈의 용도 |
MX2010005805A (es) * | 2007-11-27 | 2010-06-09 | Lifescan Inc | Diferenciacion de celulas madre embrionarias humanas. |
CN105886459A (zh) | 2008-02-21 | 2016-08-24 | 詹森生物科技公司 | 用于细胞粘附、培养和分离的方法、表面改性培养板和组合物 |
US8623648B2 (en) | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
WO2009134429A2 (en) * | 2008-05-02 | 2009-11-05 | Massachusetts Institute Of Technology | Methods and compositions for modulating immunological tolerance |
ES2697798T3 (es) | 2008-06-30 | 2019-01-28 | Janssen Biotech Inc | Diferenciación de células madre pluripotentes |
CA2729734A1 (en) * | 2008-06-30 | 2010-01-07 | Centocor Ortho Biotech Inc. | Differentiation of pluripotent stem cells |
US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
KR20180108887A (ko) * | 2008-08-20 | 2018-10-04 | 안트로제네시스 코포레이션 | 단리된 태반 세포를 사용한 뇌졸중 치료 |
EP3539380A3 (de) * | 2008-08-20 | 2019-12-18 | Celularity, Inc. | Verbesserte zellzusammensetzung und verfahren zur herstellung davon |
CA2734446C (en) * | 2008-08-22 | 2017-06-20 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
EP2350265B1 (de) * | 2008-10-31 | 2019-04-17 | Janssen Biotech, Inc. | Differenzierung menschlicher embryonaler stammzellen in die pankreatisch-endokrine linie |
CA2742268C (en) | 2008-10-31 | 2020-02-18 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
RU2562154C2 (ru) * | 2008-11-19 | 2015-09-10 | Антродженезис Корпорейшн | Амниотические адгезивные клетки |
ES2584053T3 (es) * | 2008-11-20 | 2016-09-23 | Janssen Biotech, Inc. | Métodos y composiciones para la unión de células y cultivo en sustratos planos |
JP2012509085A (ja) | 2008-11-20 | 2012-04-19 | ヤンセン バイオテツク,インコーポレーテツド | マイクロキャリア上での多能性幹細胞の培養 |
WO2010060031A1 (en) * | 2008-11-21 | 2010-05-27 | Anthrogenesis Corporation | Treatment of diseases, disorders or conditions of the lung using placental cells |
US9301975B2 (en) | 2009-05-01 | 2016-04-05 | Biocardia, Inc. | Method of preparing autologous cells and method of use for therapy |
CA2768644A1 (en) * | 2009-07-20 | 2011-01-27 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
RU2540016C2 (ru) | 2009-07-20 | 2015-01-27 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека |
MX348077B (es) | 2009-07-20 | 2017-05-25 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas. |
DK2456853T3 (da) * | 2009-07-21 | 2021-02-01 | Abt Holding Co | Anvendelse af stamceller til reduktion af leukocyt-ekstravasation |
MX350966B (es) * | 2009-10-29 | 2017-09-26 | Janssen Biotech Inc | Celulas madre pluripotentes. |
AU2010333840B2 (en) * | 2009-12-23 | 2016-01-07 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
KR101867369B1 (ko) | 2009-12-23 | 2018-06-14 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
ES2646750T3 (es) * | 2010-01-26 | 2017-12-15 | Anthrogenesis Corporation | Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias |
KR20130025375A (ko) | 2010-03-01 | 2013-03-11 | 얀센 바이오테크 인코포레이티드 | 만능 줄기 세포로부터 유래된 세포의 정제 방법 |
TWI578993B (zh) | 2010-04-07 | 2017-04-21 | 安瑟吉納西斯公司 | 利用胎盤幹細胞之血管新生 |
TW201138792A (en) | 2010-04-08 | 2011-11-16 | Anthrogenesis Corp | Treatment of sarcoidosis using placental stem cells |
CA3128483A1 (en) | 2010-05-12 | 2011-11-17 | Abt Holding Company | Modulation of splenocytes in cell therapy |
CA2800610C (en) | 2010-05-12 | 2019-09-24 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
KR20130093091A (ko) | 2010-07-13 | 2013-08-21 | 안트로제네시스 코포레이션 | 천연 킬러 세포의 생성 방법 |
CN103154237B (zh) | 2010-08-31 | 2016-03-16 | 詹森生物科技公司 | 多能干细胞的分化 |
EP2853589B1 (de) | 2010-08-31 | 2017-12-27 | Janssen Biotech, Inc. | Differenzierung menschlicher embryonaler Stammzellen |
KR101851956B1 (ko) | 2010-08-31 | 2018-04-25 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
US8895291B2 (en) | 2010-10-08 | 2014-11-25 | Terumo Bct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
EP2658557A1 (de) | 2010-12-31 | 2013-11-06 | Anthrogenesis Corporation | Verbesserung der plazentastammzellenpotenz mit modulatorischen rna-molekülen |
TWI602570B (zh) | 2011-06-01 | 2017-10-21 | 安瑟吉納西斯公司 | 使用胎盤幹細胞之疼痛治療 |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
BR112014015417A8 (pt) | 2011-12-22 | 2017-07-04 | Janssen Biotech Inc | diferenciação de células-tronco embrionárias humanas em células positivas de insulina hormonal únicas |
KR20140131999A (ko) | 2012-03-07 | 2014-11-14 | 얀센 바이오테크 인코포레이티드 | 만능 줄기 세포의 증폭 및 유지를 위한 한정 배지 |
ES2897649T3 (es) | 2012-06-08 | 2022-03-02 | Janssen Biotech Inc | Diferenciación de células madre embrionarias humanas en células endocrinas pancreáticas |
SG10201709338RA (en) | 2012-12-31 | 2017-12-28 | Janssen Biotech Inc | Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells |
CA2896658C (en) | 2012-12-31 | 2021-06-22 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators |
MX2015008619A (es) | 2012-12-31 | 2016-01-12 | Janssen Biotech Inc | Suspension y agrupamiento de celulas humanas pluripotentes para la diferenciacion a celulas endocrinas pancreaticas. |
US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
EP3622960A1 (de) | 2013-02-05 | 2020-03-18 | Celularity, Inc. | Natürliche killerzellen aus plazenta |
WO2014165581A1 (en) | 2013-04-02 | 2014-10-09 | New York University | Gpr15-mediated homing and uses thereof |
SG10201914136UA (en) | 2013-04-12 | 2020-03-30 | Saverio Lafrancesca | Improving organs for transplantation |
CN105992816B (zh) | 2013-11-16 | 2018-04-17 | 泰尔茂比司特公司 | 生物反应器中的细胞扩增 |
JP6783143B2 (ja) | 2014-03-25 | 2020-11-11 | テルモ ビーシーティー、インコーポレーテッド | 培地の受動的補充 |
EP3954759A1 (de) | 2014-05-16 | 2022-02-16 | Janssen Biotech, Inc. | Verwendung kleiner moleküle zur verstärkung der mafa-expression in endokrinen pankreaszellen |
WO2016049421A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled feed |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
MA45479A (fr) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
EP3656842A1 (de) | 2017-03-31 | 2020-05-27 | Terumo BCT, Inc. | Zellexpansion |
US11795433B2 (en) * | 2017-05-23 | 2023-10-24 | Creative Medical Technologies, Inc | Generation of autologous immune modulatory cells for treatment of neurological conditions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99864A (en) * | 1990-10-31 | 2000-11-21 | Autoimmune Inc | Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens |
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
DE69232427T2 (de) * | 1991-11-05 | 2002-11-21 | Univ Leland Stanford Junior | Suppressorzellen |
AU6816194A (en) * | 1993-04-20 | 1994-11-08 | Robinson, William S. | Methods and materials for treatment of individuals infected with intracellular infectious agents |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
DK1066052T3 (da) * | 1998-03-18 | 2006-06-12 | Osiris Therapeutics Inc | Mesenchymstamceller til forebyggelse og behandling af immunreaktioner ved transplantationer |
-
1999
- 1999-10-12 US US09/415,627 patent/US6685936B2/en not_active Expired - Lifetime
-
2000
- 2000-05-01 US US09/563,768 patent/US6281012B1/en not_active Expired - Lifetime
- 2000-10-10 WO PCT/US2000/028011 patent/WO2001026470A1/en active IP Right Grant
- 2000-10-10 PT PT00972063T patent/PT1220611E/pt unknown
- 2000-10-10 ES ES00972063T patent/ES2261250T3/es not_active Expired - Lifetime
- 2000-10-10 DK DK00972063T patent/DK1220611T3/da active
- 2000-10-10 CA CA002382737A patent/CA2382737A1/en not_active Abandoned
- 2000-10-10 AT AT00972063T patent/ATE319312T1/de active
- 2000-10-10 DE DE60026561T patent/DE60026561T2/de not_active Expired - Lifetime
- 2000-10-10 AU AU10778/01A patent/AU775647B2/en not_active Expired
- 2000-10-10 EP EP00972063A patent/EP1220611B1/de not_active Expired - Lifetime
- 2000-10-10 JP JP2001529270A patent/JP2003511398A/ja active Pending
-
2006
- 2006-06-02 CY CY20061100708T patent/CY1106437T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1220611T3 (da) | 2006-07-10 |
ATE319312T1 (de) | 2006-03-15 |
DE60026561T2 (de) | 2007-03-15 |
US20020034504A1 (en) | 2002-03-21 |
EP1220611A1 (de) | 2002-07-10 |
AU775647B2 (en) | 2004-08-12 |
JP2003511398A (ja) | 2003-03-25 |
AU1077801A (en) | 2001-04-23 |
US6685936B2 (en) | 2004-02-03 |
PT1220611E (pt) | 2006-07-31 |
US6281012B1 (en) | 2001-08-28 |
EP1220611A4 (de) | 2004-12-22 |
EP1220611B1 (de) | 2006-03-08 |
WO2001026470A1 (en) | 2001-04-19 |
CY1106437T1 (el) | 2011-10-12 |
CA2382737A1 (en) | 2001-04-19 |
ES2261250T3 (es) | 2006-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60026561D1 (de) | Suppressorzellen zur prävention und behandlung von immunantworten bei transplantationen | |
DE69929681D1 (de) | Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen | |
ATE482712T1 (de) | Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen | |
DK0987998T3 (da) | Decellulering af væv | |
DE68918285D1 (de) | Methode für behandlung von transplantaten vor transplantationen. | |
MXPA05008973A (es) | Metodo de tratamiento de rechazo de trasplante de cornea. | |
WO2004011631A3 (en) | Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus | |
NO20054912D0 (no) | Behandling av aspergillus infeksjoner med tymosin alfa 1 | |
DE69633393D1 (de) | Mitteln zur behandlung von auto-immun krankheiten | |
ATE234614T1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
WO2004009029A3 (en) | Compositions and methods for treating and preventing infection | |
TW200621986A (en) | Liver stromal cells for prevention and treatment of immune responses in transplantation | |
ES2180345T3 (es) | Nuevo procedimiento para la crio-conservacion de plantas. | |
ATE305785T1 (de) | Cd45 hemmer | |
ATE165509T1 (de) | Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund | |
UA69988A (en) | Method for treating complicated choledocholithiasis | |
UA6151U (en) | Method for treating experimental burns | |
ATE419843T1 (de) | Methode zur in vitro reduzierung von durch freie radikale induzierte schäden | |
RU2002117852A (ru) | Способ лечения больных псориазом в сочетании с хроническим описторхозом | |
ATE253378T1 (de) | Xenogene transplantation | |
UA37531A (uk) | Спосіб хірургічного лікування глибоких опіків |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. VOLKER VOSSIUS, CORINNA VOSSIUS, TILMAN VOSSIU |